Publications by authors named "Thomas M File"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

23,904

Total Likes

1,513

Extended Reach

13,332,857

Social Features

338
C
Community-Acquired Pneumonia.
Thomas M File, Julio A Ramirez

August 2023

Videos about Article: user user

2 103 3 233

View All Article and Social Media Activity
O
Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial.
Thomas M File, Keith S Kaye, Skliarov Ihor, Iryna Hovbakh, Vakhtang Katsarava

EClinicalMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia.
Thomas M File

Clin Chest Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Infections in Adults: Community-Acquired Pneumonia.
Thomas M File, Julio A Ramirez

FP Essent· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Infections in Adults: Nosocomial Pneumonia.
Thomas M File, Julio A Ramirez

FP Essent· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Infections in Adults: Pulmonary Infections in Immunocompromised Patients.
Julio A Ramirez, Thomas M File

FP Essent· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Infections in Adults: Lung Abscess and Pleural Effusion.
Julio A Ramirez, Thomas M File

FP Essent· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Perspectives on Antimicrobial Agents: Omadacycline for community-acquired pneumonia, skin and soft tissue infections, and nontuberculous mycobacteria (focus on ).
Thomas M File, Julio A Ramirez, Ashley M Wilde

Antimicrob Agents Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to assess survival prognosis in patients hospitalized for community-acquired pneumonia in 2024?
Julio A Ramirez, Thomas M File

Curr Opin Crit Care· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-Acquired Pneumonia. Reply.
Thomas M File, Julio A Ramirez

N Engl J Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Susanne Paukner, Lisa Goldberg, Elizabeth Alexander, Anita F Das, Stefanie Heinrich, Thomas M File

J Glob Antimicrob Resist· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hostage to history - questioning the duration of systemic antimicrobial therapy for the treatment of canine superficial bacterial folliculitis.
Candace A Sousa, Jenifer Chatfield, Thomas M File, Sandra N Koch, Daryl B Leu

J Am Vet Med Assoc· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria.
Susanne Paukner, Gregory J Moran, Christian Sandrock, Thomas M File, Jorge E Vidal

Future Microbiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.
Susanne Paukner, David Mariano, Anita F Das, Gregory J Moran, Christian Sandrock, Thomas M File

Antibiotics (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics.
Helen W Boucher, Thomas M File, Vance G Fowler, Amanda Jezek, John H Rex

Clin Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.
Thomas M File, Elizabeth Alexander, Lisa Goldberg, Anita F Das, Christian Sandrock

BMC Pulm Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.
Oliver A Cornely, Thomas M File, Lynne Garrity-Ryan, Surya Chitra, Robert Noble

Int J Antimicrob Agents· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia.
Richard R Watkins, Thomas M File

Clin Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections.
Thomas M File, Robin L P Jump, Debra A Goff

Infect Dis Clin North Am· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the expansion of antimicrobial stewardship services during transitions of care at an academic hospital.
Stephanie T Zampino, Paula A Politis, Susan M Fosnight, Thomas M File, M David Gothard

Infect Control Hosp Epidemiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Tang and Lai.
Thomas M File, Steven P Gelone, Jennifer Schranz, Elizabeth Alexander

Clin Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSA.
Cynthia L Sears, William G Powderly, Paul G Auwaerter, Barbara D Alexander, Thomas M File

J Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Steps Toward Ambulatory Antimicrobial Stewardship: Dental and Orthopedic Focus.
Thomas M File, Susan C Bleasdale

Clin Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections.
Stephanie Noviello, G Ralph Corey, Thomas L Holland, Thomas Lodise, William O'Riordan, Thomas M File

J Med Microbiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
Michelle L Brown, Johann Motsch, Keith S Kaye, Thomas M File, Helen W Boucher

Open Forum Infect Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis